Myriad Genetics Stock (NASDAQ: MYGN) stock price, news, charts, stock research, profile.
Open | $24.790 |
Close | $25.290 |
Volume / Avg. | 598.558K / 738.755K |
Day Range | 24.480 - 25.540 |
52 Wk Range | 13.820 - 25.950 |
Market Cap | $2.289B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 71 |
Short Interest | 9.22% |
Days to Cover | 9.62 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Myriad Genetics (NASDAQ: MYGN) through any online brokerage.
Other companies in Myriad Genetics’s space includes: MoonLake (NASDAQ:MLTX), PTC Therapeutics (NASDAQ:PTCT), Agios Pharmaceuticals (NASDAQ:AGIO), Dyne Therapeutics (NASDAQ:DYN) and ACADIA Pharmaceuticals (NASDAQ:ACAD).
The latest price target for Myriad Genetics (NASDAQ: MYGN) was reported by Piper Sandler on Monday, May 13, 2024. The analyst firm set a price target for 28.00 expecting MYGN to rise to within 12 months (a possible 10.72% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Myriad Genetics (NASDAQ: MYGN) is $25.29 last updated May 17, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Myriad Genetics.
Myriad Genetics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Myriad Genetics.
Myriad Genetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.